UNSPSC 51183615: Insulin lispro

This classification denotes a therapeutic insulin with the molecular formula C257H383N65O77S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GFX7QIS1II, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

UNSPSC 51183615 Insulin lispro is a Commodity code covering the procurement of insulin lispro, a rapid-acting insulin analog used in diabetes management. State and local governments purchase insulin lispro primarily through their health and human services departments, Medicaid programs, correctional health systems, and public health clinics to serve eligible populations including low-income beneficiaries, incarcerated individuals, and those receiving care in state-operated facilities. The drug is typically procured as a finished pharmaceutical product—vials, pens, or cartridges—either as a standalone purchase or as part of broader diabetes medication contracts that may bundle multiple insulin formulations or diabetes-management supplies.

The source provides no recent state and local contract opportunities tagged to this code, and therefore no data on issuing-body concentration, geographic spread, or representative recent solicitations.